Monitor Screen 13-Drug Class Profile (Labcorp MedWatch®)

CPT: 80307

Test Includes

Amphetamine; barbiturate; benzodiazepines; cocaine; fentanyl; meperidine; methadone; opiates; oxycodone/oxymorphone; phencyclidine (PCP); propoxyphene; tetrahydrocannabinol (THC); tramadol


Special Instructions

This profile is designed for pain management. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs.


Expected Turnaround Time

1 - 3 days


Specimen Requirements


Specimen

Urine (random)


Volume

30 mL


Container

Urine container


Storage Instructions

Maintain specimen at room temperature. If arrival at lab extends beyond seven days, refrigerate.


Test Details


Use

Detect the presence of prescribed and illicit drugs


Limitations

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).


Methodology

Immunoassay (IA)


For Providers

Please login to order a test

Order a Test

© 2025 Laboratory Corporation of America® Holdings. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf